This is the authors' abstract. We don't add key points for this paper.
BACKGROUND: Oral immunotherapy (OIT) is an increasingly popular but still contentious treatment option for food allergies. Because most patients receiving OIT are children, families' involvement in treatment is an important part of the discussion of the appropriateness of this treatment option for individual patients. OBJECTIVE: To explore how US-based allergists judge whether OIT is a good fit for specific patients and their families. METHODS: Providers were recruited through direct solicitation by email to participate in an in-depth interview about their perceptions of the risks and benefits of current and future food allergy treatment options, including OIT. RESULTS: A total of 60 interviews were conducted with academic and community providers from 34 states. The primary finding was that as part of the shared decision-making process for OIT, providers actively assessed families' levels of anxiety and investment in this treatment option. They were seeking levels of both that were "just right" and found families with both too low and too high levels of anxiety and investment as a poor fit for OIT. CONCLUSION: Providers used assessments of family anxiety and investment as mechanisms to optimize the benefits and minimize the risk of harm to their patients from OIT and to streamline staffing burdens in their practices.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Erol et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: